Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.9% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.47% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BXRX
2326
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
| $2.02M | ﹤0.01% |
+208
| New | +$1.77M |
|
|
FGH
2327
DELISTED
FG Group Holdings Inc.
FGH
| $2.01M | ﹤0.01% |
619,003
+7,800
| +1% | +$22K |
|
2328
LSB Industries
LXU
$783M
| $2M | ﹤0.01% |
620,099
+96,850
| +19% | +$327K |
|
|
EVBN
2329
DELISTED
Evans Bancorp Inc
EVBN
| $2M | ﹤0.01% |
49,931
+5,131
| +11% | +$200K |
|
2330
BK Technologies
BKTI
$300M
| $2M | ﹤0.01% |
128,940
+1,720
| +1% | +$27.7K |
|
2331
Citizens Financial Group
CFG
$30.3B
| $1.99M | ﹤0.01% |
49,000
-858,000
| -95% | -$32.1M |
|
2332
Coastal Financial
CCB
$626M
| $1.99M | ﹤0.01% |
120,777
+14,334
| +13% | +$232K |
|
2333
Regal Rexnord
RRX
$13.7B
| $1.99M | ﹤0.01% |
23,200
-77,700
| -77% | -$6.16M |
|
2334
Donaldson
DCI
$10.9B
| $1.98M | ﹤0.01% |
34,400
-30,629
| -47% | -$1.67M |
|
2335
Invesco CEF Income Composite ETF
PCEF
$801M
| $1.97M | ﹤0.01% |
84,630
+42,030
| +99% | +$957K |
|
2336
State Street SPDR S&P Retail ETF
XRT
$449M
| $1.96M | ﹤0.01% |
+42,549
| New | +$1.87M |
|
|
TRVN
2337
DELISTED
Trevena, Inc.
TRVN
| $1.96M | ﹤0.01% |
3,719
+344
| +10% | +$176K |
|
|
RCM
2338
DELISTED
R1 RCM Inc. Common Stock
RCM
| $1.95M | ﹤0.01% |
150,398
-517,205
| -77% | -$5.91M |
|
2339
Build-A-Bear
BBW
$425M
| $1.95M | ﹤0.01% |
602,078
-239,888
| -28% | -$770K |
|
2340
Amerant Bancorp
AMTB
$1.16B
| $1.95M | ﹤0.01% |
89,303
+23,203
| +35% | +$483K |
|
|
YRD
2341
Yiren Digital
YRD
$97.1M
| $1.95M | ﹤0.01% |
350,565
+335,065
| +2,162% | +$1.96M |
|
2342
Western Midstream Partners
WES
$19.2B
| $1.94M | ﹤0.01% |
+98,705
| New | +$2.05M |
|
2343
Peoples Bancorp of North Carolina
PEBK
$229M
| $1.94M | ﹤0.01% |
59,092
+3,700
| +7% | +$113K |
|
|
HNP
2344
DELISTED
Huaneng Power Intl, Inc.
HNP
| $1.94M | ﹤0.01% |
96,500
-7,500
| -7% | -$145K |
|
2345
State Street Health Care Select Sector SPDR ETF
XLV
$41.9B
| $1.94M | ﹤0.01% |
19,000
-147,300
| -89% | -$14.2M |
|
|
BBQ
2346
DELISTED
BBQ Holdings, Inc. Common Stock
BBQ
| $1.93M | ﹤0.01% |
491,699
+17,452
| +4% | +$83.1K |
|
2347
Walker & Dunlop
WD
$1.71B
| $1.93M | ﹤0.01% |
29,789
-66,711
| -69% | -$4.22M |
|
|
FRGI
2348
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $1.92M | ﹤0.01% |
194,466
+40,000
| +26% | +$376K |
|
2349
Microbot Medical
MBOT
$116M
| $1.92M | ﹤0.01% |
188,775
-12,774
| -6% | -$74.9K |
|
2350
CB Financial Services
CBFV
$186M
| $1.92M | ﹤0.01% |
63,641
+1,124
| +2% | +$31.9K |
|
Similar funds
Renaissance Technologies's Q4 2019 Portfolio in Review
As of Q4 2019, Renaissance Technologies held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Renaissance Technologies's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Renaissance Technologies added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Renaissance Technologies's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Renaissance Technologies fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Renaissance Technologies's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Renaissance Technologies opened 518 new positions and closed 443 in Q4 2019.
- Renaissance Technologies's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.